TREATMENT of disseminated colon carcinoma must still be considered experimental.1 Fluorinated pyrimidines, the cornerstone of treatment, yield only a 20% response rate and have had little impact on survival.1 Immunotherapy with BCG vaccine has been reported to produce encouraging results in uncontrolled trials.2 However, the role of immunotherapy in disseminated colonic cancer has yet to be established. We herein report a remission of a patient with metastatic adenocarcinoma of the colon treated with fluorouracil and BCG vaccine.
Report of a Case
A 30-year-old woman was initially seen at the Michael Reese Medical Center, Chicago, in 1967 (aged 18 years) with rectal bleeding. Her father had died of colon cancer at 45 years of age. Roentgenograms of the colon disclosed a mass lesion within the cecum, consistent with adenocarcinoma. An exploratory laparotomy confirmed the diagnosis, and a right-sided hemicolectomy was performed. The tumor extended into the muscularis. Lymph
Shapiro CM, Bitran JD, Shapiro RA. Remission of Metastatic Adenocarcinoma of the Colon. JAMA. 1983;250(18):2503–2504. doi:10.1001/jama.1983.03340180057026
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: